Headline News about Merck & Co
A Closer Look at Merck & Co's Options Market Dynamics
October 11, 2024
Via Benzinga
18 Stocks To Buy, 7 To Sell This Earnings Season: Goldman Sachs Calls It 'The Year Of The Stock Picker'
October 10, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Demystifying Merck & Co: Insights From 8 Analyst Reviews
October 03, 2024
Via Benzinga
Jim Cramer Says He's Buying 'Some Target,' But Dismisses SoundHound AI As 'Meme Stock'
October 09, 2024
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
10 Health Care Stocks Whale Activity In Today's Session
October 07, 2024
Via Benzinga
This Is What Whales Are Betting On Merck & Co
September 25, 2024
Via Benzinga
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
October 04, 2024
Via Benzinga
Exposures
Product Safety
Merck & Co Unusual Options Activity For September 23
September 23, 2024
Via Benzinga
Via News Direct
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
September 25, 2024
Via Benzinga
Exposures
Product Safety
Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
September 25, 2024
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.